A nice pullback by VEEV poses a lucrative buying opportunity due to these 3 main reasons. 1) Business is resistant to macro headwinds. 2) The company has thrived since COVID due to securing contracts with pharmaceutical giants AstraZeneca and Merck. 3) Growing at an very fast rate and increasing operational margins.
